Literature DB >> 24710121

Adherence Patterns to National Comprehensive Cancer Network Guidelines for Referral of Women With Breast Cancer to Genetics Professionals.

Ashley Stuckey1, Terri Febbraro, Jessica Laprise, Jennifer S Wilbur, Vrishali Lopes, Katina Robison.   

Abstract

OBJECTIVE: Genetic predisposition is responsible for 5% to 10% of breast cancer. The National Comprehensive Cancer Network (NCCN) established guidelines delineating appropriate candidates for genetic counseling. This study aims to determine referral patterns for genetic counseling in women who met such guidelines.
MATERIALS AND METHODS: Utilizing an institutional tumor registry, patients from an academic oncology program who met a subset of NCCN guidelines for genetic referrals between 2004 and 2010 were identified (breast cancer diagnosis ≤50 y without a known BRCA mutation). A retrospective chart review was conducted. Statistics were analyzed using SAS version 9.2.
RESULTS: A total of 314 patients were identified and 107 (34.1%) were referred for genetic counseling. Median age at diagnosis was younger for those referred versus not referred (43 and 46 y; P<0.0001). Women were more likely referred with a family history suspicious for an inherited cancer syndrome (67.3% vs. 36.2%; P<0.0001). There was no difference in stage at diagnosis, insurance, or race among women referred. Those patients who choose prophylactic contralateral mastectomy were likely to have been referred for genetic counseling (63.6% vs. 36.4%, P<0.0001). Among patients referred, 77.6% consulted with a genetics counselor, 95.2% underwent genetic testing, and 16.5% had a BRCA mutation.
CONCLUSIONS: Genetic counseling and testing is being underutilized in women who meet NCCN referral guidelines. Age and family history were noted to be predictive of referral for genetic evaluation. Further research is needed to determine additional factors that may impact not only referral rates but subsequent care for women with possible genetic predispositions to cancer.

Entities:  

Mesh:

Year:  2016        PMID: 24710121     DOI: 10.1097/COC.0000000000000073

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  26 in total

1.  BRCA1 and BRCA2 Mutation Testing in Young Women With Breast Cancer.

Authors:  Shoshana M Rosenberg; Kathryn J Ruddy; Rulla M Tamimi; Shari Gelber; Lidia Schapira; Steven Come; Virginia F Borges; Bryce Larsen; Judy E Garber; Ann H Partridge
Journal:  JAMA Oncol       Date:  2016-06-01       Impact factor: 31.777

2.  The Time for Mainstreaming Germline Testing for Patients With Breast Cancer Is Now.

Authors:  Padma Sheila Rajagopal; Daniel V T Catenacci; Olufunmilayo I Olopade
Journal:  J Clin Oncol       Date:  2019-06-27       Impact factor: 44.544

Review 3.  Racial/Ethnic Disparities in BRCA Counseling and Testing: a Narrative Review.

Authors:  Christina D Williams; Alyssa Jasmine Bullard; Meghan O'Leary; Reana Thomas; Thomas S Redding; Karen Goldstein
Journal:  J Racial Ethn Health Disparities       Date:  2019-04-08

4.  National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.

Authors:  Christopher P Childers; Kimberly K Childers; Melinda Maggard-Gibbons; James Macinko
Journal:  J Clin Oncol       Date:  2017-08-18       Impact factor: 44.544

5.  Impact of a randomized controlled educational trial to improve physician practice behaviors around screening for inherited breast cancer.

Authors:  Robert A Bell; Haley McDermott; Tonya L Fancher; Michael J Green; Frank C Day; Michael S Wilkes
Journal:  J Gen Intern Med       Date:  2014-12-02       Impact factor: 5.128

6.  Utilization of genetic testing in breast cancer treatment after implementation of comprehensive multi-disciplinary care.

Authors:  Samfee Doe; Shariska Petersen; Monique Swain
Journal:  Breast J       Date:  2020-01-09       Impact factor: 2.431

7.  Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.

Authors:  D Cragun; D Bonner; J Kim; M R Akbari; S A Narod; A Gomez-Fuego; J D Garcia; S T Vadaparampil; Tuya Pal
Journal:  Breast Cancer Res Treat       Date:  2015-04-14       Impact factor: 4.872

8.  Health beliefs associated with readiness for genetic counseling among high risk breast cancer survivors.

Authors:  Maija Reblin; Monica L Kasting; Kelli Nam; Courtney L Scherr; Jongphil Kim; Ram Thapa; Cathy D Meade; M Catherine Lee; Tuya Pal; Gwendolyn P Quinn; Susan T Vadaparampil
Journal:  Breast J       Date:  2018-11-28       Impact factor: 2.431

9.  The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial.

Authors:  Charles W Drescher; J David Beatty; Robert Resta; M Robyn Andersen; Kate Watabayashi; Jason Thorpe; Sarah Hawley; Hannah Purkey; Jessica Chubak; Nancy Hanson; Diana S M Buist; Nicole Urban
Journal:  Cancer       Date:  2016-07-22       Impact factor: 6.860

10.  Deleterious BRCA1/2 mutations in an urban population of Black women.

Authors:  Filipa Lynce; Karen Lisa Smith; Julie Stein; Tiffani DeMarco; Yiru Wang; Hongkun Wang; Melissa Fries; Beth N Peshkin; Claudine Isaacs
Journal:  Breast Cancer Res Treat       Date:  2015-08-07       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.